From Wikipedia, the free encyclopedia
Jump to: navigation, search
ADAM metallopeptidase domain 8
Available structures
PDB Ortholog search: PDBe, RCSB
Symbols ADAM8 ; CD156; CD156a; MS2
External IDs OMIM602267 MGI107825 HomoloGene74384 GeneCards: ADAM8 Gene
EC number 3.4.24.-
RNA expression pattern
PBB GE ADAM8 205180 s at tn.png
PBB GE ADAM8 205179 s at tn.png
More reference expression data
Species Human Mouse
Entrez 101 11501
Ensembl ENSG00000151651 ENSMUSG00000025473
UniProt P78325 Q05910
RefSeq (mRNA) NM_001109 NM_001291066
RefSeq (protein) NP_001100 NP_001277995
Location (UCSC) Chr 10:
133.26 – 133.28 Mb
Chr 7:
139.98 – 139.99 Mb
PubMed search [1] [2]

A Disintegrin and metalloproteinase domain-containing protein 8 is an enzyme that in humans is encoded by the ADAM8 gene.[1][2]


This gene encodes a member of the ADAM (a disintegrin and metalloproteinase domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene may be involved in cell adhesion during neurodegeneration.[2]

See also[edit]


  1. ^ Yoshiyama K, Higuchi Y, Kataoka M, Matsuura K, Yamamoto S (Apr 1997). "CD156 (human ADAM8): expression, primary amino acid sequence, and gene location". Genomics 41 (1): 56–62. doi:10.1006/geno.1997.4607. PMID 9126482. 
  2. ^ a b "Entrez Gene: ADAM8 ADAM metallopeptidase domain 8". 

Further reading[edit]

  • Yamamoto S, Higuchi Y, Yoshiyama K, Shimizu E, Kataoka M, Hijiya N, Matsuura K (Jun 1999). "ADAM family proteins in the immune system". Immunology Today 20 (6): 278–84. doi:10.1016/S0167-5699(99)01464-4. PMID 10354553. 
  • Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW (Nov 2000). "Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration". The Journal of Neuroscience 20 (21): 7964–71. PMID 11050116. 
  • Amour A, Knight CG, English WR, Webster A, Slocombe PM, Knäuper V, Docherty AJ, Becherer JD, Blobel CP, Murphy G (Jul 2002). "The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs". FEBS Letters 524 (1-3): 154–8. doi:10.1016/S0014-5793(02)03047-8. PMID 12135759. 
  • Ishikawa N, Daigo Y, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y (Dec 2004). "ADAM8 as a novel serological and histochemical marker for lung cancer". Clinical Cancer Research 10 (24): 8363–70. doi:10.1158/1078-0432.CCR-04-1436. PMID 15623614. 
  • Foley SC, Mogas AK, Olivenstein R, Fiset PO, Chakir J, Bourbeau J, Ernst P, Lemière C, Martin JG, Hamid Q (Apr 2007). "Increased expression of ADAM33 and ADAM8 with disease progression in asthma". The Journal of Allergy and Clinical Immunology 119 (4): 863–71. doi:10.1016/j.jaci.2006.12.665. PMID 17339047. 
  • Gómez-Gaviro M, Domínguez-Luis M, Canchado J, Calafat J, Janssen H, Lara-Pezzi E, Fourie A, Tugores A, Valenzuela-Fernández A, Mollinedo F, Sánchez-Madrid F, Díaz-González F (Jun 2007). "Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding". Journal of Immunology 178 (12): 8053–63. doi:10.4049/jimmunol.178.12.8053. PMID 17548643. 
  • Valkovskaya N, Kayed H, Felix K, Hartmann D, Giese NA, Osinsky SP, Friess H, Kleeff J (2008). "ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer". Journal of Cellular and Molecular Medicine 11 (5): 1162–74. doi:10.1111/j.1582-4934.2007.00082.x. PMID 17979891. 

External links[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.